Your browser doesn't support javascript.
loading
Resurgence of Bordetella pertussis, including one macrolide-resistant isolate, France, 2024.
Rodrigues, Carla; Bouchez, Valérie; Soares, Anaïs; Trombert-Paolantoni, Sabine; Aït El Belghiti, Fatima; Cohen, Jérémie F; Armatys, Nathalie; Landier, Annie; Blanchot, Thomas; Hervo, Marie; Toubiana, Julie; Brisse, Sylvain.
Afiliación
  • Rodrigues C; These authors contributed equally to this work and share first authorship.
  • Bouchez V; National Reference Center for Whooping Cough and other Bordetella infections, Institut Pasteur, Paris, France.
  • Soares A; Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.
  • Trombert-Paolantoni S; These authors contributed equally to this work and share first authorship.
  • Aït El Belghiti F; National Reference Center for Whooping Cough and other Bordetella infections, Institut Pasteur, Paris, France.
  • Cohen JF; Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.
  • Armatys N; Laboratoire Eurofins Biomnis, Lyon, France.
  • Landier A; Laboratoire Cerba, Saint Ouen l'Aumône, France.
  • Blanchot T; Santé publique France, Infectious Diseases Department, The French Public Health Agency, Saint-Maurice, France.
  • Hervo M; Centre for Research in Epidemiology and Statistics (Inserm UMR 1153), Université Paris Cité, Paris, France.
  • Toubiana J; National Reference Center for Whooping Cough and other Bordetella infections, Institut Pasteur, Paris, France.
  • Brisse S; Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.
Euro Surveill ; 29(31)2024 Aug.
Article en En | MEDLINE | ID: mdl-39092529
ABSTRACT
As other European countries, France is experiencing a resurgence of pertussis in 2024. Between 1 January and 31 May 2024, 5,616 (24.9%) positive Bordetella pertussis qPCR tests were identified, following a 3-year period of almost null incidence. Of 67 cultured and whole genome sequenced B. pertussis isolates, 66 produced pertactin and 56 produced FIM2, in contrast to pre-COVID-19 years. One isolate of genotype Bp-AgST4 was resistant to macrolides. Pertussis resurgence may favour isolates that produce FIM2 and pertactin.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bordetella pertussis / Tos Ferina / Macrólidos / Antibacterianos Límite: Adult / Child / Child, preschool / Humans País/Región como asunto: Europa Idioma: En Revista: Euro Surveill Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2024 Tipo del documento: Article Pais de publicación: Suecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bordetella pertussis / Tos Ferina / Macrólidos / Antibacterianos Límite: Adult / Child / Child, preschool / Humans País/Región como asunto: Europa Idioma: En Revista: Euro Surveill Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2024 Tipo del documento: Article Pais de publicación: Suecia